Previous studies showed a significant increase of FABP3 in CSF of AD patients [30, 32, 45, 46], as well as in other neurodegenerative disorders, including Creutzfeldt-Jacob disease (CJD), vascular dementia (VAD), and Dementia with Lewy Bodies (DLB) [32, 47, 48], while no data were available for FTD patients before our work. This evidence concerns the gene FABP3 and Creutzfeldt Jacob disease.